Today: 17 June 2026
NIO Inc Earnings Preview: China EV Maker Faces Crucial Margin Test After Rare Profit Alert
27 May 2026
2 mins read

NIO Stock Jumps as Yao Ming-Backed SUV Launches; Big Test Ahead

New York, May 27, 2026, 13:04 (EDT)

NIO Inc. shares were up 8.6% at $5.71 Wednesday afternoon in New York, after the Chinese EV company rolled out its new ES9 flagship SUV and brought on basketball player Yao Ming as the face of the launch. Volume topped 60 million shares, with the stock hitting an intraday high of $5.79.

NIO’s launch is in focus as investors look at it as a test for the company’s turnaround story. NIO is under pressure to show new upscale models can boost deliveries and margins. The company has pushed for fast growth but spent heavily as it took on tough competition in China’s electric-vehicle market.

NIO launched the ES9 in Beijing on Wednesday, picking Yao to front the model as it aims for more recognition overseas. According to Reuters, NIO says the ES9 is China’s largest battery-electric SUV, with space for six people and 13 suitcases. The SUV runs on NIO’s Shenji NX9031 self-driving chip and its homegrown operating system.

NIO CEO William Li told Reuters last month the growth of Chinese EV makers is a “significant opportunity” to shake up the high-end and luxury auto segment. That’s NIO’s pitch to investors now: the company says it wants not just higher volumes but a better product mix and a stronger premium brand. Reuters

ES9 pricing starts at 498,000 yuan, or 390,000 yuan with NIO’s Battery-as-a-Service plan, which lets buyers lease the battery instead of buying it. The first ES9 variant is set for deliveries from May 28, and another version will follow in July, CarNewsChina reported.

NIO’s Q1 results add more detail to the stock action. The EV maker said it delivered 83,465 vehicles for the quarter, up 98.3% on the year but down 33.1% from the prior quarter. Revenue came in at 25.53 billion yuan. Vehicle margin improved to 18.8%.

NIO CEO Li said in the earnings release the company was in an “intensive new product launch and delivery cycle.” The company guided second-quarter deliveries between 110,000 and 115,000 vehicles, looking for revenue of 32.78 billion yuan to 34.44 billion yuan. NIO Inc.

NIO CFO Stanley Yu Qu said the EV maker will “further enhance cost and operational efficiency” after reporting first-quarter adjusted net profit of 43.5 million yuan. The company still logged a net loss by standard accounting, though. NIO Inc.

Competitive pressure remains high. Reuters said BYD’s Denza premium line brought in British actor Daniel Craig for its latest global campaign, while EV media compares the ES9 to big premium SUVs like Li Auto’s L9. NIO is trying to set itself apart with battery swapping, offering a new battery in minutes instead of waiting at a charging station. Reuters

NIO jumped in afternoon trading while Li Auto and XPeng’s U.S. shares slipped, pointing to a move tied to NIO’s model launch and delivery hopes. The action suggested investors were picking NIO instead of making a sector-wide bet on Chinese EV stocks.

The risk is clear. Should ES9 orders not lead to steady deliveries, or if the price war in China pushes NIO to make deeper cuts, the stock may lose its recent gains. NIO’s first-quarter deliveries dropped from the fourth quarter. Battery swapping is still unproven outside China, where there are fewer networks and new consumer patterns. NIO Inc.

So far, NIO is getting a nod from the market for its launch. Now traders will watch if the ES9 plus new ONVO lines help hit Q2 goals, all without undoing the margin gains that set this round of earnings apart from older recoveries.

Stock Market Today

  • Moderna (MRNA) Launches November 20th Options with Attractive Strike Prices
    June 17, 2026, 11:23 AM EDT. Moderna Inc (MRNA) now offers new options expiring November 20, emphasizing time value with 156 days until expiration. Notably, a $55.00 put option is trading with a bid of $9.05, enabling sellers to effectively buy shares at a $45.95 cost basis, which is 3% below current stock price of $56.58. The put has a 64% chance to expire worthless, yielding a 16.45% return on cash committed, or 38.49% annualized, per Stock Options Channel's YieldBoost metric. On the call side, a $60.00 strike covered call bids at $10.60, offering a potential 24.78% return if shares rise to that level by expiration. Both strike prices are analyzed relative to Moderna's trailing twelve-month stock history, presenting investors strategic premium capture opportunities ahead of November expiry.

Latest articles

Dow slips in New York after jobs data boosts rate-hike talk

Dow steady near high as traders wait for Fed decision

17 June 2026
In this article, you will find answers to your questions: Why did the Dow Jones Industrial Average rise while the S&P 500 and Nasdaq fell? What are traders expecting from the Federal Reserve’s policy decision under new Chair Kevin Warsh? How did strong May retail sales and moves in chip stocks impact the market? What risks could threaten the Dow’s record push?
AI Names Drop, Oil Upends Inflation Bets, US Stocks Slip

Wall Street mixed with Fed in focus, chip stocks bounce

17 June 2026
In this article you will find answers to your questions such as: How did the Dow, S&P 500, and Nasdaq perform this morning? What are investors expecting from the Federal Reserve’s rate decision under new Chair Kevin Warsh? How did May retail sales impact inflation concerns? Which sectors are leading or lagging in the market today? What could a hawkish Fed tone mean for Treasury yields and stocks?
Jabil lifts outlook on strong AI data-center demand; shares rise

Jabil lifts outlook on strong AI data-center demand; shares rise

17 June 2026
Did Jabil raise its fiscal 2026 revenue and profit forecasts? Yes, Jabil raised its fiscal 2026 revenue forecast to $35 billion and adjusted profit view to $12.70 a share, both above Wall Street expectations. How did the stock react to the news? Jabil shares rose about 9.8% to $412.29 after the company beat fiscal third-quarter estimates and lifted its 2026 outlook.
Boston Scientific Hits Two-Year Low After Watchman Device Warning
Previous Story

Boston Scientific Hits Two-Year Low After Watchman Device Warning

IREN Limited’s Nvidia Deal Rewrites The Bitcoin-Miner AI Cloud Trade
Next Story

IREN Shares Jump After $1.6 Billion Dell Agreement Puts Focus on AI Revenue Target

Go toTop